Former lab member Emma Wilkinson joined the Committee on Cancer Biology at the University of Chicago last September!

For more information, go to the Mullin Fund Scholars website.

Recently hired Post Doc Gepoliano Chaves is joining the lab next month!

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic of Outcome in Neuroblastoma: An International Neuroblastoma Risk Group (INRG) project. DOI:10.1200/JCO.19.03285

So honored to be named to the to 40 under 40 Chicago scientists! https://www.halocures.com/translation/mark-applebaum-uchicago/

Kelley Moore has joined the lab! We’re all excited for her to work on some new protocols for understanding neuroblastoma epigenetics.

5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype. https://ascopubs.org/doi/10.1200/PO.18.00402

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. https://www.ncbi.nlm.nih.gov/pubmed/30674566

For more information, go to the BSD website.